Anorexigenic melanocortin signaling in the hypothalamus is augmented in association with failure-to-thrive in a transgenic mouse model for Prader-Willi syndrome

Brain Research

Volumn 957, Issue 1, 2002, Pages 42-45

  Ge, Yin Lin ^a   Ohta, Tohru ^b   Driscoll, Daniel J ^a   Nicholls, Robert D ^b   Kalra, Satya P ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Hypothalamus; Melanocortin signaling; Neonatal mouse; Neuropeptide; Prader Willi Syndrome; Transgenic mouse

Indexed keywords

AGOUTI RELATED PROTEIN; ALPHA INTERMEDIN; ANOREXIGENIC AGENT; MELANOCORTIN; MELANOCORTIN 4 RECEPTOR; MESSENGER RNA; NEUROPEPTIDE Y; PEPTIDE;

ANIMAL MODEL; APPETITE; ARTICLE; CONTROLLED STUDY; FAILURE TO THRIVE; GENDER; GENETIC STRAIN; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MOUSE; NEWBORN; NEWBORN PERIOD; NONHUMAN; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; RODENT; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE;

ANIMALS; ANIMALS, NEWBORN; ANOREXIA; ARCUATE NUCLEUS; DISEASE MODELS, ANIMAL; FEMALE; IN SITU HYBRIDIZATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, TRANSGENIC; NEUROPEPTIDE Y; PRADER-WILLI SYNDROME; PRO-OPIOMELANOCORTIN; PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 0037032614     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03583-7     Document Type: Article

References (10)

1. Dhillon H., Kalra S.P., Kalra P.S. Dose-dependent effects of central leptin gene therapy on genes that regulate body weight and appetite in the hypothalamus. Mol. Ther. 4:2001;139-145.
2. Dimitropoulos A., Feurer I.D., Roof E., Stone W., Butler M.G., Sutcliffe J., Thompson T. Appetitive behavior, compulsivity, and neurochemistry in Prader-Willi syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 6:2000;125-130.
3. Fan W., Boston B.A., Kesterson R.A., Hruby V.J., Cone R.D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. 385:1997;165-168.
4. Gabriel J.M., Merchant M., Ohta T., Ji Y., Caldwell R.G., Ramsey M.J., Tucker J.D., Longnecker R., Nicholls R.D. A transgene insertion creating a heritable chromosome deletion mouse model of Prader-Willi and angelman syndromes. Proc. Natl. Acad. Sci. USA. 96:1999;9258-9263.
5. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
6. Kalra S.P., Dube M.G., Pu S., Xu B., Horvath T.L., Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20:1999;68-100.
7. Kowalski T.J., Ster A.M., Smith G.P. Increased hypothalamic neuropeptide Y expression in deprived preweanling rats is reversed by intragastric infusion of milk. Physiol. Behav. 75:2002;425-432.
8. Nagai T., Mori M. Prader-Willi syndrome, diabetes mellitus and hypogonadism. Biomed. Pharmacother. 53:1999;452-454.
9. Nicholls R.D., Knepper J.L. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annu. Rev. Genomics Hum. Genet. 2:2001;153-175.
10. Yang T., Adamson T.E., Resnick J.L., Leff S., Wevrick R., Francke U., Jenkins N.A., Copeland N.G., Brannan C.I. A mouse model for Prader-Willi syndrome imprinting-centre mutations. Nat. Genet. 19:1998;25-31.